Taken from page 10 of the updated prospectus.

Jamestown Facility. The Company has disclosed that during 2024, it anticipates it will begin limited operations at its 137,000 square foot facility in Jamestown, New York. Such limited operations may include activities such as warehousing operations, final assembly and testing, which the Company expects it can achieve without any material capital expenditures. No capital expenditures on the Jamestown facility have been incurred to date and the Issuer has not committed to any such expenditures. Capital expenditures on Jamestown are only expected to proceed in the event that the Company obtains a government backed debt facility that includes advantageous terms with minimal impacts to operating cash flow and equity dilution to support such expenditures.